These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2884896)

  • 21. Vecuronium infusion requirements in paediatric patients in intensive care units: the use of acceleromyography.
    Hodges UM
    Br J Anaesth; 1996 Jan; 76(1):23-8. PubMed ID: 8672374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide.
    Szenohradszky J; Caldwell JE; Wright PM; Brown R; Lau M; Luks AM; Fisher DM
    Anesthesiology; 1999 Jan; 90(1):24-35. PubMed ID: 9915309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vecuronium in pediatric anesthesia. Repeated bolus vs continuous infusion].
    Barbone G; Longo G; Bruno F
    Minerva Anestesiol; 1992 Mar; 58(3):105-9. PubMed ID: 1350330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-tetanic count and intense neuromuscular blockade with vecuronium in children.
    Ridley SA; Braude N
    Br J Anaesth; 1988 Nov; 61(5):551-6. PubMed ID: 2905144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of vecuronium and atracurium in continuous infusion. A comparative study using electromyography and accelerometry].
    Alvarez Gómez JA; Pérez Guillermo F; Bernal García G; Palacios Sánchez MA; Bernal García JJ
    Rev Esp Anestesiol Reanim; 1990; 37(2):58-62. PubMed ID: 1971119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous infusion of vecuronium: the effect of anesthetic agents.
    Cannon JE; Fahey MR; Castagnoli KP; Furuta T; Canfell PC; Sharma M; Miller RD
    Anesthesiology; 1987 Oct; 67(4):503-6. PubMed ID: 2889403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in vecuronium infusion dose requirements by nicardipine in humans.
    Kawabata K; Sumikawa K; Kamibayashi T; Kita T; Takada K; Mashimo T; Yoshiya I
    Anesth Analg; 1994 Dec; 79(6):1159-64. PubMed ID: 7978442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of computer-controlled versus manual administration of vecuronium in humans.
    Jaklitsch RR; Westenskow DR; Pace NL; Streisand JB; East KA
    J Clin Monit; 1987 Oct; 3(4):269-76. PubMed ID: 2890719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of propofol, isoflurane and sevoflurane on vecuronium infusion rates for surgical muscle relaxation in dogs.
    Nagahama S; Nishimura R; Mochizuki M; Sasaki N
    Vet Anaesth Analg; 2006 May; 33(3):169-74. PubMed ID: 16634942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of vecuronium administered by the Springfusor infusion device to vecuronium by intermittent bolus injection in critically ill adult patients.
    Freebairn R; Joynt GM; Lipman J; Bothma PA
    Anaesth Intensive Care; 1994 Oct; 22(5):580-5. PubMed ID: 7818063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mivacurium infusion requirements following vecuronium: different response between adults and children.
    Denman W; Goudsouzian N
    Can J Anaesth; 1995 Jul; 42(7):597-602. PubMed ID: 7553995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism.
    Roland EJ; Wierda JM; Eurin BG; Roupie E
    Can J Anaesth; 1994 Aug; 41(8):694-8. PubMed ID: 7923517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vecuronium by continuous infusion for neuromuscular blockade in infants and children.
    Eldadah MK; Newth CJ
    Crit Care Med; 1989 Oct; 17(10):989-92. PubMed ID: 2571460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The magnitude and time course of vecuronium potentiation by desflurane versus isoflurane.
    Wright PM; Hart P; Lau M; Brown R; Sharma ML; Gruenke L; Fisher DM
    Anesthesiology; 1995 Feb; 82(2):404-11. PubMed ID: 7856899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vecuronium and atracurium in patients with end-stage renal failure. A comparative study.
    Lepage JY; Malinge M; Cozian A; Pinaud M; Blanloeil Y; Souron R
    Br J Anaesth; 1987 Aug; 59(8):1004-10. PubMed ID: 2888474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prediction of the maintenance dose of vecuronium for continuous infusion].
    Amaki Y; Kumagai M; Takinami M; Miyano K; Kobayashi K
    Masui; 1991 Jan; 40(1):66-71. PubMed ID: 1675700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of betamethasone on neuromuscular blockade induced by vecuronium in continuous infusion].
    Nocente M; Colcerasa P; Zema M; Bellomonte L; Vecchia P; Sanfilippo M
    Minerva Anestesiol; 1994 Nov; 60(11):687-92. PubMed ID: 7761019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rate of injection on the neuromuscular block produced by vecuronium.
    Feldman SA; Soni N; Kraayenbrink MA
    Anesth Analg; 1989 Nov; 69(5):624-6. PubMed ID: 2572184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atracurium infusions in patients with renal failure on an ITU.
    Griffiths RB; Hunter JM; Jones RS
    Anaesthesia; 1986 Apr; 41(4):375-81. PubMed ID: 3518532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.